- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.
Scope of the Report:
This report focuses on the Cancer Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors' patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient's immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.
Asia-Pacific witnessed the highest growth rate for cancer vaccines in 2016, and is expected to continue this trend throughout the forecast period. This is attributed to large population base, rise in incidence of HPV infection related cancers & other cancer cases, healthcare infrastructural development, and huge market potential. Moreover, the introduction of novel preventive, therapeutic, and adult cancer vaccines in the market alo
The worldwide market for Cancer Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Market Segment by Applications, can be divided into
Cervical Cancer
Prostate Cancer
Others
There are 15 Chapters to deeply display the global Cancer Vaccines market.
Chapter 1, to describe Cancer Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Vaccines, with sales, revenue, and price of Cancer Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Preventive Cancer Vaccines
1.2.2 Therapeutic Cancer Vaccines
1.3 Market Analysis by Applications
1.3.1 Cervical Cancer
1.3.2 Prostate Cancer
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Glaxosmithkline
2.1.1 Business Overview
2.1.2 Cancer Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Glaxosmithkline Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Astellas Pharma
2.2.1 Business Overview
2.2.2 Cancer Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Astellas Pharma Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Cancer Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 CSL Limited
2.4.1 Business Overview
2.4.2 Cancer Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CSL Limited Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanpower Group
2.5.1 Business Overview
2.5.2 Cancer Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanpower Group Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi Pasteur
2.6.1 Business Overview
2.6.2 Cancer Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Pasteur Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Cancer Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Serum Institute of India
2.8.1 Business Overview
2.8.2 Cancer Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Serum Institute of India Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Vaccines Market Analysis by Regions
4.1 Global Cancer Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Cancer Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Vaccines Sales and Growth Rate (2013-2018)
5 North America Cancer Vaccines by Countries
5.1 North America Cancer Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Vaccines Sales and Growth Rate (2013-2018)
6 Europe Cancer Vaccines by Countries
6.1 Europe Cancer Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Cancer Vaccines Sales and Growth Rate (2013-2018)
6.4 France Cancer Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Vaccines by Countries
7.1 Asia-Pacific Cancer Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Vaccines Sales and Growth Rate (2013-2018)
7.5 India Cancer Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Vaccines Sales and Growth Rate (2013-2018)
8 South America Cancer Vaccines by Countries
8.1 South America Cancer Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Vaccines by Countries
9.1 Middle East and Africa Cancer Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Vaccines Sales and Growth Rate (2013-2018)
10 Global Cancer Vaccines Market Segment by Type
10.1 Global Cancer Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Preventive Cancer Vaccines Sales Growth and Price
10.2.1 Global Preventive Cancer Vaccines Sales Growth (2013-2018)
10.2.2 Global Preventive Cancer Vaccines Price (2013-2018)
10.3 Therapeutic Cancer Vaccines Sales Growth and Price
10.3.1 Global Therapeutic Cancer Vaccines Sales Growth (2013-2018)
10.3.2 Global Therapeutic Cancer Vaccines Price (2013-2018)
11 Global Cancer Vaccines Market Segment by Application
11.1 Global Cancer Vaccines Sales Market Share by Application (2013-2018)
11.2 Cervical Cancer Sales Growth (2013-2018)
11.3 Prostate Cancer Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Cancer Vaccines Market Forecast (2018-2023)
12.1 Global Cancer Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Vaccines Market Forecast (2018-2023)
12.2.2 Europe Cancer Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Vaccines Market Forecast (2018-2023)
12.2.4 South America Cancer Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Vaccines Market Forecast (2018-2023)
12.3 Cancer Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Vaccines Market Share Forecast by Type (2018-2023)
12.4 Cancer Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Vaccines Picture
Table Product Specifications of Cancer Vaccines
Figure Global Sales Market Share of Cancer Vaccines by Types in 2017
Table Cance
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
